SPH Phililab  received a tentative approval letter from the FDA on Eslicarbazspine Tablets 200 mg, 400 mg, 600 mg and 800 mg (for SPH Shanghai Zhongxi Pharmaceutical Co. Ltd).

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt